中成药质量标准局限性探讨  

Discussion on Limitation of Quality Standards of Chinese Patent Medicine

作　　者：万仁甫[1] 肖宏浩[1] 曾一心[1] 

机构地区：[1]江西中医学院药学院,江西南昌市330004

出　　处：《中国执业药师》2010年第10期31-34,共4页China Licensed Pharmacist

摘　　要：本文通过系统查阅中成药标准的相关文献,广视角、多层面地进行中成药标准局限性的分析,同时结合我国近年来中药严重不良反应/事件进行实证分析。旨在探讨当前中成药质量标准存在的局限性。以达到提高对中成药标准的局限性在企业道德缺失的市场环境下产生巨大危害的认识,强化中成药质量再评价措施,提高中成药质量,减少药害事件的发生,保障患者用药安全的目的。To discuss the questions of limitation of quality standards of Chinese patent medicine by systematically consullting Chinese patent medicine standard＇s related literature,fully analyzing the limitation of quality standards of Chinese patent medicine and empirically analyzing the Chinese patent medicine serious adverse drug effects in recent years in our country.Aim to make significant cognition of the huge harm of the quality standard limitation of Chinese patent medicine produced under the market environment with lack of the enterprise morals and to insist the importance of strengthing and improving the Chinese patent medicine quality re-evaluation measures and the traditional Chinese medicine quality to reduce the drug damage event＇s occurrence and to safeguard the patient security.

关 键 词：中成药 质量标准 局限性 

分 类 号：R286.0[医药卫生—中药学]